Autoimmune inner ear disease patient–associated 28-kDa proinflammatory IL-1β fragment results from caspase-7–mediated cleavage in vitro
Open Access
- 13 February 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
Abstract
Interleukin-1β (IL-1β) is a key proinflammatory cytokine involved in the progression of many autoinflammatory and autoimmune diseases, including autoimmune inner ear disease (AIED). IL-1β inhibition has been shown to result in clinical hearing improvement in a small cohort of corticosteroid-resistant patients with AIED. Canonical processing of pro–IL-1β by caspase-1 generates an active 17-kDa fragment, capable of instigating a proinflammatory microenvironment. However, in response to LPS, PBMCs from patients with AIED uniquely express a 28-kDa IL-1β fragment, as compared with PBMCs from control subjects. We synthesized and compared the biologic activity of the 28-kDa fragment to the 17-kDa IL-1β product and the pro–IL-1 31-kDa protein. The 28-kDa IL-1β fragment induces IL-6, TNF-α, and CCL3 in PBMCs. Uniquely, only caspase-7 treatment showed a dose- and time-dependent increase in 28-kDa band generation. Mass spectrometry confirmed the putative caspase-7 cleavage site of pro–IL-1β, which was used to generate the 28-kDa fragment used for PBMC stimulation studies. Collectively, these results provide insight into the function of a poorly understood, processed 28-kDa form of IL-1β in patients with AIED that is uniquely generated by caspase-7 and is capable of activating further downstream proinflammatory cytokines. Further investigation may provide novel pharmacologic targets for the treatment of this rare disease.Funding Information
- NIDCD, NIH & Merrill & Phoebe Goodman Otology Reserch Center (R33DC011827)
This publication has 64 references indexed in Scilit:
- Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) ActivityOnline Journal of Public Health Informatics, 2011
- IL‐1β induces expression of matrix metalloproteinase‐9 and cell migration via a c‐Src‐dependent, growth factor receptor transactivation in A549 cellsBritish Journal of Pharmacology, 2010
- Dual functionality of interleukin‐1 family cytokines: implications for anti‐interleukin‐1 therapyBritish Journal of Pharmacology, 2009
- Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIEDPLOS ONE, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survivalBlood, 2009
- Executioner caspase-3 and caspase-7 are functionally distinct proteasesProceedings of the National Academy of Sciences of the United States of America, 2008
- Stimulation of Toll-like receptor 3 and 4 induces interleukin-1β maturation by caspase-8The Journal of Experimental Medicine, 2008
- Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitisThe Journal of Experimental Medicine, 2006
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992